‘There Is a Very Large and Significant Pipeline of Opportunities, but Questions Remain as to When That Activity Actually Transacts’

Paul Tomasic, Managing Director and Head of European Healthcare at Houlihan Lokey, speaks with HealthInvestor UK, providing insights into the rise of “non-process” processes in M&A activity, buyers’ preferences for structured timelines, and the shift toward more intentional deal preparation.

Read more here.